Cargando…

A germline 1;3 translocation disrupting the VHL gene: a novel genetic cause for von Hippel-Lindau

Von Hippel-Lindau (VHL) disease is an autosomal dominant hereditary tumour susceptibility disease caused by germline pathogenic variation of the VHL tumour suppressor gene. Affected individuals are at risk of developing multiple malignant and benign tumours in a number of organs. In this report, a m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ricketts, Christopher J, Vocke, Cathy D, Lang, Martin, Chen, Xiongfong, Zhao, Yongmei, Tran, Bao, Tandon, Mayank, Schmidt, Laura S, Ball, Mark W, Linehan, W Marston
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Cancer Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080673/ https://www.ncbi.nlm.nih.gov/pubmed/33067352 http://dx.doi.org/10.1136/jmedgenet-2020-107308

Ejemplares similares

Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations
por: Shen, H.-C. Jennifer, et al.
Publicado: (2009)

Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors
por: Moore, Lee E., et al.
Publicado: (2011)

Patient-specific factors influence somatic variation patterns in von Hippel–Lindau disease renal tumours
por: Fei, Suzanne S., et al.
Publicado: (2016)

Comprehensive characterization of Alu‐mediated breakpoints in germline VHL gene deletions and rearrangements in patients from 71 VHL families
por: Vocke, Cathy D., et al.
Publicado: (2021)

Germline mutations in the new E1’ cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma
por: Buffet, Alexandre, et al.
Publicado: (2020)

Hemangioblast: origin of hemangioblastoma in von Hippel-Lindau (VHL) syndrome
por: Wang, Herui, et al.
Publicado: (2018)

The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis
por: Hudler, Petra, et al.
Publicado: (2022)

Obstructive azoospermia secondary to bilateral epididymal cystadenomas in a patient with von Hippel-Lindau
por: Gomella, Patrick T., et al.
Publicado: (2019)

Von Hippel–Lindau Disease (VHL): Characteristic Lesions with Classic Imaging Findings
por: Bajaj, Suryansh, et al.
Publicado: (2023)

Von Hippel–Lindau (VHL) small-molecule inhibitor binding increases stability and intracellular levels of VHL protein
por: Frost, Julianty, et al.
Publicado: (2021)

Molecular Characterization of a Novel Germline VHL Mutation by Extensive In Silico Analysis in an Indian Family with Von Hippel-Lindau Disease
por: Arunachal, Gautham, et al.
Publicado: (2016)

Hypoxia-inducible factor underlies von Hippel-Lindau disease stigmata
por: Ohh, Michael, et al.
Publicado: (2022)

Expression of Von Hippel – Lindau (VHL) gene mutation in diagnosed cases of renal cell carcinoma
por: Shahzad, Humera, et al.
Publicado: (2014)

The von Hippel–Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform
por: Chesnel, F, et al.
Publicado: (2015)

A novel mutation in the VHL gene in a Chinese family with von Hippel-Lindau disease
por: Wu, Xing, et al.
Publicado: (2018)

Clinical diagnosis, treatment and screening of the VHL gene in three von Hippel-Lindau disease pedigrees
por: Lin, Guobing, et al.
Publicado: (2020)

Von Hippel-Lindau Disease
por: Hes, Frederik J, et al.
Publicado: (2005)

An optimized protocol for evaluating pathogenicity of VHL germline variants in patients suspected with von Hippel-Lindau syndrome: Using somatic genome to inform the role of germline variants
por: Koeller, Diane R., et al.
Publicado: (2022)

Sequencing of Von Hippel-Lindau (VHL) Gene from Genomic DNA for Mutation Detection in Italian Patients
por: Akanni, OE, et al.
Publicado: (2006)

Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel–Lindau Disease
por: Hong, Baoan, et al.
Publicado: (2019)

SUN-194 Adrenal Incidentaloma to Pheochromocytoma (Variant of Unknown Significance of Von Hippel Lindau Syndrome, VHL)
por: Oo, Yin Htwe
Publicado: (2020)

Von-Hippel Lindau (VHL) syndrome with bilateral cerebellar hemangioblastomas and retinal angiomas: A rare presentation
por: Acharya, Abhijit, et al.
Publicado: (2023)

Von Hippel-Lindau Disease and the Eye
por: Karimi, Saeed, et al.
Publicado: (2020)

A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C
por: Schreinemakers, Jennifer MJ, et al.
Publicado: (2007)

Design and Analysis of a Petri Net Model of the Von Hippel-Lindau (VHL) Tumor Suppressor Interaction Network
por: Minervini, Giovanni, et al.
Publicado: (2014)

Functioning Mediastinal Paraganglioma Associated with a Germline Mutation of von Hippel-Lindau Gene
por: Bahougne, Thibault, et al.
Publicado: (2018)

Retinal haemangioblastomas in von Hippel–Lindau germline mutation carriers: progression, complications and treatment outcome
por: Hajjaj, Anass, et al.
Publicado: (2020)

Loss of Von Hippel–Lindau (VHL) Tumor Suppressor Gene Function: VHL–HIF Pathway and Advances in Treatments for Metastatic Renal Cell Carcinoma (RCC)
por: Kim, Hyunho, et al.
Publicado: (2021)

Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction
por: Buckley, Dennis L., et al.
Publicado: (2012)

A Review of Von Hippel-Lindau Syndrome
por: Varshney, Neha, et al.
Publicado: (2017)

Cardiac Involvement in Von Hippel-Lindau Disease
por: Valero, Ernesto, et al.
Publicado: (2016)

Ocular Manifestations of von Hippel-Lindau Disease
por: Ruppert, Misty D, et al.
Publicado: (2019)

Shorter telomere length increases age‐related tumor risks in von Hippel‐Lindau disease patients
por: Wang, Jiang‐Yi, et al.
Publicado: (2017)

Novel interactions of the von Hippel-Lindau (pVHL) tumor suppressor with the CDKN1 family of cell cycle inhibitors
por: Minervini, Giovanni, et al.
Publicado: (2017)

Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders
por: Diehl, Claudia J., et al.
Publicado: (2022)

The incidence of consecutive manifestations in Von Hippel-Lindau disease
por: van der Horst-Schrivers, Anouk N. A., et al.
Publicado: (2019)

Von Hippel-Lindau Syndrome: Medical Syndrome or Surgical Syndrome? A Surgical Perspective
por: Coco, Danilo, et al.
Publicado: (2021)

Clear cell chondrosarcoma in Von Hippel-Lindau disease
por: Dreijerink, Koen M. A., et al.
Publicado: (2019)

Recurrent lobular capillary hemangiomas in a patient with neurofibromatosis type 1 (NF1) and von Hippel-Lindau syndrome (VHL)
por: Haitz, Karyn, et al.
Publicado: (2015)

Inactivation of the tumor suppressor gene von Hippel-Lindau (VHL) in granulocytes contributes to development of liver hemangiomas in a mouse model
por: Bader, Hannah L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_62i2v36kqrf3gpcfhq1haoc41s